35 articles for Y Inoue
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis and antibacterial activity of new tetracyclic quinolone antibacterials.

Kanebo
Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.

Dainippon Sumitomo Pharma
Design and biological evaluation of imidazo[1,2-a]pyridines as novel and potent ASK1 inhibitors.

Takeda Pharmaceutical
New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.

Nippon Organon K.K.
Study on selectin blocker. 8. Lead discovery of a non-sugar antagonist using a 3D-pharmacophore model.

Nippon Organon K.K.
Studies on selectin blockers. 7. Structure-activity relationships of sialyl Lewis X mimetics based on modified Ser-Glu dipeptides.

Kanebo
Studies on selectin blockers. 6. Discovery of homologous fucose sugar unit necessary for E-selectin binding.

Kanebo
Studies on selectin blocker. 1. Structure-activity relationships of sialyl Lewis X analogs.

Institute of Cancer Research
Studies on antiulcer drugs. 7. 2-Guanidino-4-pyridylthiazoles as histamine H2-receptor antagonists with potent gastroprotective effects against nonsteroidal antiinflammatory drug-induced injury.

Fujisawa Pharmaceutical
Synthesis and SAR study of imidazoquinolines as a novel structural class of microsomal prostaglandin E2 synthase-1 inhibitors.

Dainippon Sumitomo Pharma
Azasugar-based MMP/ADAM inhibitors as antipsoriatic agents.

Hokkaido Collaboration Center N-21
Synthesis and biological activity of selective azasugar-based TACE inhibitors.

Organon K.K.
Design, synthesis and evaluation of novel azasugar-based MMP/ADAM inhibitors.

Hokkaido Collaboration Center
Structure--activity relationships of azasugar-based MMP/ADAM inhibitors.

Hokkaido Collaboration Center
Discovery of selective phosphonamide-based inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).

Organon K.K.
Design and synthesis of peptide-based carboxylic acid-containing transition-state inhibitors of human neutrophil elastase.

Dainippon Pharmaceutical
New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs.

Organon K.K.
An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.

Nagoya Citi University
Peptidyl human heart chymase inhibitors. 2. Discovery of highly selective difluoromethylene ketone derivatives with Glu at P3 site.

Green Cross Research Laboratories
Peptidyl human heart chymase inhibitors. 1. Synthesis and inhibitory activity of difluoromethylene ketone derivatives bearing P' binding subsites.

Green Cross Research Laboratories
Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M(1) and M(4) muscarinic acetylcholine receptors agonists.

Dainippon Sumitomo Pharma
Compounds

Astex Therapeutics
Pyrrolotriazine kinase inhibitors

Bristol-Myers Squibb
Small molecule activators of NRF2 pathway

The General Hospital
Bicyclic heterocycles as bet protein inhibitors

Incyte
Ether compounds for treatment of complement mediated disorders

Achillion Pharmaceuticals
RAF kinase modulator compounds and methods of use thereof

Ambit Biosciences
Kinase inhibitors and methods of their use

Novartis
Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases.

Abbott Laboratories
1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors.

Procter & Gamble Pharmaceuticals
Synthesis, pharmacological evaluation, and molecular modeling studies of novel peptidic CAAX analogues as farnesyl-protein-transferase inhibitors.

Universita Di Napoli Federico Ii
Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.

University of Washington At Seattle
2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase i

Bristol-Myers Squibb
Design, synthesis, and evaluation of a potent, cell-permeable, conformationally constrained second mitochondria derived activator of caspase (Smac) mimetic.

University of Michigan
Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site.

University of Michigan